Incremental Hemodialysis for End-Stage Kidney Disease

Incremental Hemodialysis: The TwoPlus Trial

Recruiting N/A Interventional Study
End-Stage Kidney Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
350 (estimated)
Sponsor
Wake Forest University Health Sciences · Other
Who this trial is looking for

This trial is looking for adults with kidney problems who need dialysis. Participants will either start a new type of dialysis called incremental hemodialysis or a traditional one. The trial will follow them for about two years to compare the outcomes.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old.
  • I have kidney problems that require dialysis.
  • I have been on dialysis for 12 weeks or less.
  • I have a kidney urea clearance of at least 2.0 mL/min.
  • I produce at least 500 mL of urine in 24 hours.

You may not be able to join if

  • I have high potassium or low sodium levels before dialysis.
  • I need a large amount of fluid removal during dialysis.
  • I cannot follow the study rules for any reason.
  • I am pregnant or planning to become pregnant.
  • I expect to change my dialysis method or center within the next 6 months.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is to prospectively compare clinical effectiveness between clinically- matched incremental hemodialysis and conventional hemodialysis in patients with incident kidney dysfunction requiring dialysis and residual kidney function. The study will enroll 350 patients on chronic hemodialysis and 140 caregivers of enrolled patients. Patients will be randomized in 1:1 ratio to either increment…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Patient eligibility Criteria: Inclusion Criteria: * Clinical Inclusion Criteria: * Age ≥ 18 years * Incident kidney dysfunction requiring dialysis (KDRD) started on maintenance, in-center hemodialysis (HD), or anticipated to be started on maintenance, in-center HD within the next 12 weeks * Has re…
Contacts

Brenda Burciu

336-716-8671

Brindusa.Burciu@advocatehealth.org

CONTACT